is bpc-157 on fda 503a bulks list Breaking News: The Panel just voted by a narrow margin to include BPC- 157 to be included the bulk drug substance list. There was a vigorous debate about the lack of BPC-157 Legal Status: FDA Regulations

BPC 157 Legal Status: FDA Regulations and Compounding Next week, July 23 24, the FDA's Pharmacy Compounding Advisory Committee will review seven peptides being considered for inclusion on the 503A Bulks List: BPC 157, KPV, TB 500, MOTS c, DSIP, Semax Ways2Well The FDA just dropped a 68 page PDF on if BPC 157 should be legal or not to compound. Their initial recommendation: DO NOT add BPC 157 to the 503A Bulks List. They're meeting this Peptides meeting is just a week away, 23 24 July. Massive catalyst for $HIMS & $ENHA. The FDA's Pharmacy Compounding Advisory Committee is scheduled to review seven peptide families for possible inclusion on A majority of FDA's Pharmacy Compounding Advisory Committee voted in favor of allowing bulk compounding of BPC 157 #PCAC #peptides 3 FOR 3. An FDA advisory committee has now voted 86, with one abstention, to recommend BPC 157, KPV and TB 500 for inclusion on the 503A Bulks List. This is not FDA approval

SKU: 19711096869 · From southroadsurgery.com.au